Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in HUMA — Humacyte, Inc.

CIK 886982 NEW YORK, NY
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$457,488
+$46,541 QoQ
Shares Held
586,524
-13.4% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 163 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. HUMA ranks #291 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in HUMA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $457,488 586,524
2026-03-31 $410,947 677,015
2025-12-31 $410,574 427,238
2025-09-30 $851,310 489,259
2025-06-30 $1,332,740 637,675
2025-03-31 $879,264 515,698
2024-12-31 $3,170,015 627,726
2024-09-30 $4,528,853 832,510
2024-06-30 $3,655,560 761,575
2024-03-31 $307,429 98,852
2023-12-31 $286,004 100,706
2023-09-30 $388,312 132,530
2023-06-30 $213,209 74,549
2023-03-31 $194,307 62,883
2022-12-31 $117,302 55,594
2022-09-30 $233,930 71,758
2022-06-30 $137,718 42,903
2022-03-31 $677,519 95,966
2021-12-31 $563,216 77,685